Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions

SARS-CoV-2 infection was announced as a pandemic in March 2020. Since then, several scientists have focused on the low prevalence of smokers among hospitalized COVID-19 patients. These findings led to our hypothesis that the Nicotinic Cholinergic System (NCS) plays a crucial role in the manifestatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexandris, Nikolaos, Lagoumintzis, George, Chasapis, Christos T., Leonidas, Demetres D., Papadopoulos, Georgios E., Tzartos, Socrates J., Tsatsakis, Aristidis, Eliopoulos, Elias, Poulas, Konstantinos, Farsalinos, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776751/
https://www.ncbi.nlm.nih.gov/pubmed/33425684
http://dx.doi.org/10.1016/j.toxrep.2020.12.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776751/
https://www.ncbi.nlm.nih.gov/pubmed/33425684
http://dx.doi.org/10.1016/j.toxrep.2020.12.013

Ejemplares similares